HENLIUS
Summary
Henlius is a global biopharmaceutical company offering biologic medicines for patients suffering from oncology, autoimmune and ophthalmic diseases.
Deals Overview
Total Deals1
Valued Deals1
Total Value£543M
Avg. Deal Size£543M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
